Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 46

Sort by

Sort Order Select

Journal Articles

Day 100 Peripheral Blood Natural Killer Cell/CD14+HLA-DR - Ratio Predicts Clinical Outcomes in Lymphoma Patients Treated with Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation

Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Jose C. Villasboas, Jonas Paludo, Urshila Durani, Svetomir N. Markovic

Blood (2022) 140 (Supplement 1): 10577–10578.

https://doi.org/10.1182/blood-2022-163724

Published: 2022

Journal Articles

Immunologic Autograft Engineering: 13 Years Follow-up

Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Jose C. Villasboas, Jonas Paludo, Svetomir N. Markovic

Blood (2021) 138 (Supplement 1): 3936.

https://doi.org/10.1182/blood-2021-148454

Published: 2021

Journal Articles

Autograft-Absolute Lymphocyte Count Infusion Predicts Survival in Double/Triple Hit Lymphomas Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation

Luis F. Porrata, David J. Inwards, Stephen M. Ansell, Ivana N. Micallef, Patrick B. Johnston, Jose Villasboas, Jonas Paludo, Svetomir N. Markovic

Blood (2021) 138 (Supplement 1): 1836.

https://doi.org/10.1182/blood-2021-144345

Published: 2021

Journal Articles

Infused Autograft-Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B-Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched-Control Study

Edwin Burgstaler, Luis F. Porrata, MD, Jeffrey L. Winters, MD, Eapen K. Jacob, MD, David J. Inwards, MD, Stephen M. Ansell, MD PhD, Ivana Micallef, MD, Patrick B. Johnston, Jose C Villasboas, MD, Jonas Paludo, MD, Svetomir N. Markovic, MD PhD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-133854

Published: 2020

Journal Articles

Early Fever Detection By a Novel Wearable Continuous Temperature Monitor in Patients Undergoing Autologous Stem Cell Transplantation

Jesus Vera-Aguilera, MD, Iman Haji-Abolhassani, PhD, Kimary Kulig, PhD MPH, Roxana Heitz, PhD, Jonas Paludo, MD, Atiyeh Ghoreyshi, PhD, Jordan R. Scheevel, B.A.S., Jill M. Schimke, M.S., Svetomir N. Markovic, MD PhD

Blood (2019) 134 (Supplement_1): 3481.

https://doi.org/10.1182/blood-2019-125159

Published: 2019

Journal Articles

Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution

Saad Sirop Kenderian, Thomas M. Habermann, William R. Macon, Kay M. Ristow, Stephen M. Ansell, Joseph P. Colgan, Patrick B. Johnston, David J. Inwards, Svetomir N. Markovic, Ivana N. Micallef, Carrie A. Thompson, Luis F. Porrata, James A. Martenson, Thomas E. Witzig, Grzegorz S. Nowakowski

Blood (2016) 127 (16): 1960–1966.

https://doi.org/10.1182/blood-2015-08-665505

Published: 2016

Journal Articles

Dendritic Cell Vaccine Treatment for B-Cell Non-Hodgkin Lymphoma: Clinical Trial in Progress

Blood (2014) 124 (21): 4474.

https://doi.org/10.1182/blood.V124.21.4474.4474

Published: 2014

Journal Articles

Infused Autograft Lymphocyte to Monocyte Ratio and Survival in Classical Hodgkin Lymphoma

Luis F. Porrata, MD, David J. Inwards, MD, Stephen M. Ansell, MD PhD, Ivana N. Micallef, MD, Patrick B. Johnston, MD PhD, William Hogan, MD, Svetomir N. Markovic, MD, PhD

Blood (2014) 124 (21): 1189.

https://doi.org/10.1182/blood.V124.21.1189.1189

Published: 2014

Journal Articles

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio Recovery During RCHOP Treatment Cycles Predicts Clinical Outcomes In Diffuse Large B-Cell Lymphoma

Luis F. Porrata, MD, Kay M. Ristow, Thomas M Habermann, MD, Thomas E Witzig, MD, Joseph P. Colgan, MD, David J. Inwards, MD, Stephen M Ansell, M.D. Ph.D., Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, Grzegorz S. Nowakowski, MD, Carrie A Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2013) 122 (21): 4306.

https://doi.org/10.1182/blood.V122.21.4306.4306

Published: 2013

Journal Articles

Germline Genetic Variation and Risk of Follicular Lymphoma Transformation in the Modern Treatment Era

James R Cerhan, MD, PhD, Grzegorz S. Nowakowski, MD, Matthew J Maurer, MS, Bridget Charbonneau, PhD, Herve Ghesquieres, MD, PhD, Anne J. Novak, Ph.D., Yan W Asmann, PhD, Ahmet Dogan, MD, PhD, Svetomir N. Markovic, MD, PhD, Carrie A. Thompson, MD, Stephen M. Ansell, M.D., Ph.D., George J. Weiner, MD, Brian K Link, MD, Thomas M Habermann, MD, Susan L Slager, PhD

Blood (2012) 120 (21): 149.

https://doi.org/10.1182/blood.V120.21.149.149

Published: 2012

Journal Articles

Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution

Saad J. Sirop, MD, Thomas M Habermann, MD, William R Macon, MD, Kay M. Ristow, Stephen M Ansell, MD, PhD, Joseph P Colgan, MD, Patrick B. Johnston, MD, PhD, David J. Inwards, MD, Svetomir N. Markovic, MD, PhD, Ivana N. Micallef, MD, Carrie Thompson, MD, Luis F. Porrata, MD, James A. Martenson, Jr., MD, James R Cerhan, MD, PhD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD

Blood (2012) 120 (21): 1525.

https://doi.org/10.1182/blood.V120.21.1525.1525

Published: 2012

Journal Articles

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Interim Positron-Emission Tomography in Predicting Progression-Free Survival and Time to Progression in Classical Hodgkin Lymphoma (HL)

Luis F. Porrata, MD, Kay M. Ristow, Thomas M. Habermann, Thomas E Witzig, Joseph P. Colgan, MD, David J. Inwards, MD, Stephen M. Ansell, M.D., Ph.D., Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2012) 120 (21): 1527.

https://doi.org/10.1182/blood.V120.21.1527.1527

Published: 2012

Journal Articles

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio Recovery During ABVD Treatment Cycles Predicts Clinical Outcomes in Classical Hodgkin Lymphoma (HL).

Luis F. Porrata, MD, Kay M. Ristow, Thomas M Habermann, MD, Thomas E. Witzig, MD, Joseph P. Colgan, MD, David J. Inwards, MD, Stephen M Ansell, M.D., Ph.D., Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2012) 120 (21): 2634.

https://doi.org/10.1182/blood.V120.21.2634.2634

Published: 2012

Journal Articles

Primary Parotid MALT Lymphoma: Clinical Characteristics and Treatment – a Single Institution Experience

Jason M. Jones, MD, Thomas M. Habermann, MD, Kay M. Ristow, Paul Kurtin, MD, Ellen McPhail, MD, Carrie A. Thompson, MD, Joseph P. Colgan, MD, Luis F. Porrata, MD, Svetomir N. Markovic, MD, PhD, Thomas E. Witzig, MD, James A. Martenson, Jr., MD, Grzegorz S. Nowakowski, MD

Blood (2011) 118 (21): 1580.

https://doi.org/10.1182/blood.V118.21.1580.1580

Published: 2011

Journal Articles

The Absolute Monocyte Count Predicts Overall Survival In Patients Newly Diagnosed with Follicular Lymphoma

Ryan A. Wilcox, MD, PhD, Kay M. Ristow, Thomas M. Habermann, MD, David J Inwards, MD, Ivana N. Micallef, MD, Patrick B. Johnston, Joseph P. Colgan, MD, Grzegorz S. Nowakowski, MD, Stephen M. Ansell, MD, PhD, Thomas E. Witzig, MD, Svetomir N. Markovic, MD, PhD, Luis F. Porrata, MD

Blood (2011) 118 (21): 85.

https://doi.org/10.1182/blood.V118.21.85.85

Published: 2011

Journal Articles

In Patients Newly Diagnosed with Chronic Lymphocytic Leukemia the Absolute Monocyte Count At Presentation Is Directly Associated with Disease Progression Independently From Rai Staging or Cytogenetics

Ryan A. Wilcox, MD, PhD, Kari Rabe, MS, Neil Kay, MD, Timothy G. Call, MD, Svetomir N. Markovic, MD, PhD, Luis F. Porrata, MD, Susan Schwager, Clive S. Zent, MD, Curtis A. Hanson, MD, Tait D. Shanafelt, MD

Blood (2011) 118 (21): 2835.

https://doi.org/10.1182/blood.V118.21.2835.2835

Published: 2011

Journal Articles

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Cell of Origin in Predicting Survival in Diffuse Large B-Cell Lymphoma,

Luis F. Porrata, MD, Kay M. Ristow, Joseph P. Colgan, MD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, David James Inwards, MD, Stephen M. Ansell, MD, PhD, Ivana N. Micallef, MD, Patrick B. Johnston, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2011) 118 (21): 3652.

https://doi.org/10.1182/blood.V118.21.3652.3652

Published: 2011

Journal Articles

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis and Survival in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,

Blood (2011) 118 (21): 3642.

https://doi.org/10.1182/blood.V118.21.3642.3642

Published: 2011

Journal Articles

Utility of Stem Cell Collection in Anticipation of Future Need for Autologous Stem Cell Transplant in Follicular Lymphoma Patients

Robin R. Klebig, MSN, CNP, Stephen M. Ansell, MD, PhD, Joseph P. Colgan, MD, Dennis A. Gastineau, MD, Thomas M. Habermann, MD, Patrick B. Johnston, Svetomir N. Markovic, MD, PhD, Ivana N. Micallef, MD, Grzegorz S. Nowakowski, MD, Luis F. Porrata, MD, Kay M. Ristow, Carrie A. Thompson, MD, Jessica N. Towns, PA-C, Thomas E. Witzig, MD, David J. Inwards, MD

Blood (2011) 118 (21): 1926.

https://doi.org/10.1182/blood.V118.21.1926.1926

Published: 2011

Journal Articles

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Blood (2011) 118 (18): 4882–4889.

https://doi.org/10.1182/blood-2011-02-334904

Published: 2011

NARROW

Day 100 Peripheral Blood Natural Killer Cell/CD14+HLA-DR - Ratio Predicts Clinical Outcomes in Lymphoma Patients Treated with Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation

Immunologic Autograft Engineering: 13 Years Follow-up

Autograft-Absolute Lymphocyte Count Infusion Predicts Survival in Double/Triple Hit Lymphomas Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation

Infused Autograft-Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B-Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched-Control Study

Early Fever Detection By a Novel Wearable Continuous Temperature Monitor in Patients Undergoing Autologous Stem Cell Transplantation

Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution

Dendritic Cell Vaccine Treatment for B-Cell Non-Hodgkin Lymphoma: Clinical Trial in Progress

Infused Autograft Lymphocyte to Monocyte Ratio and Survival in Classical Hodgkin Lymphoma

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio Recovery During RCHOP Treatment Cycles Predicts Clinical Outcomes In Diffuse Large B-Cell Lymphoma

Germline Genetic Variation and Risk of Follicular Lymphoma Transformation in the Modern Treatment Era

Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Interim Positron-Emission Tomography in Predicting Progression-Free Survival and Time to Progression in Classical Hodgkin Lymphoma (HL)

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio Recovery During ABVD Treatment Cycles Predicts Clinical Outcomes in Classical Hodgkin Lymphoma (HL).

Primary Parotid MALT Lymphoma: Clinical Characteristics and Treatment – a Single Institution Experience

The Absolute Monocyte Count Predicts Overall Survival In Patients Newly Diagnosed with Follicular Lymphoma

In Patients Newly Diagnosed with Chronic Lymphocytic Leukemia the Absolute Monocyte Count At Presentation Is Directly Associated with Disease Progression Independently From Rai Staging or Cytogenetics

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Cell of Origin in Predicting Survival in Diffuse Large B-Cell Lymphoma,

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis and Survival in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,

Utility of Stem Cell Collection in Anticipation of Future Need for Autologous Stem Cell Transplant in Follicular Lymphoma Patients

Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only